Abstract
Improved first progression-free survival following allogeneic hematopoietic cell transplantation relapse with the use of immunotherapy.
© 2024 Wiley Periodicals LLC.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Allografts
-
Female
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Male
-
Middle Aged
-
Philadelphia Chromosome*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / mortality
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / therapy
-
Recurrence*
-
Transplantation, Homologous*
-
Treatment Outcome